Saint Francis Hospital and Medical Center
Hartford, Connecticut, 06105, United States
NCT Number: NCT01409278
The purpose of this study is to examine three different ways to control pain after hip replacement:
1. One time injection of ropivacaine before wound closure 2. One time injection of ropivacaine before wound closure plus slow release of ropivacaine via catheter for 48 hours 3. Standard practice of patient controlled pump
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Hartford, Connecticut, 06105, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
50ml ropivacaine 0.2% with keterolac 15mg infiltration followed by normal saline infusion at 5ml per hour
50 ml infiltration of ropivacaine 0.2% and ketorolac 15mg admixture followed by ropivacaine 0.2 % at 5ml per hour infusion for 48 hours.
50ml of normal saline infiltration followed by normal saline infusion at 5ml per hour
Time frame: 48 hours after surgery
Time frame: 48 hours after surgery
Trinity Health Of New England
Other
The Evaluation of the Efficacy of Local Infiltration Analgesia and Infusion for Total Hip Arthroplasty
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02108496
Arthritis, Joint Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT07720024
Arthritis, Blount disease
Pathum Thani, Changwat Pathum Thani, Thailand
View Trial DetailsNCT01818401
Arthritis, Joint Diseases
Nantes, France
View Trial DetailsNCT07710404
Arthritis, Joint Diseases
Faisalābad, Punjab Province, Pakistan
View Trial Details